Purchase Order 36C24822P1935
- Not listed
- This federal contract award is for reagents with a ceiling value of $34,397.44. The prime contractor is Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 1 (VISN 1), with an ultimate completion date of August 14, 2025. Roche...
- This federal contract award to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment, provides $553,387.58 in firm fixed-price funding for the supply of reagents and consumables. The contract was awarded on October 10, 2024 by the Department of Veterans Affairs' Veterans Integrated Service Network 22, a civilian agency, with an ultimate completion date of April 9, 2025. The contract is not set aside for any specific business type. Roche...
- This is a federal contract award to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, with a ceiling value of $1,082,896.47, is for the provision of molecular diagnostics analyzer reagents on a rental basis. The contract was awarded by the U.S. Department of Veterans Affairs, specifically the Veterans Integrated Service Network 8, and has an ultimate...
- This federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and related laboratory equipment, was made by the Department of Veterans Affairs (VA) through Veterans Integrated Service Network 23. The $323,373.27 firm fixed-price purchase order is for the supply of reagents with a period of performance ending on March 31, 2018. The contract has no set-aside designation. Roche Diagnostics has a long history of providing critical...
- This federal contract award is to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded a $337,097.55 firm-fixed-price purchase order to Roche Diagnostics for the lease of ROCHE COBAS 6800 and the provision of COVID-19 reagents and...
- This is a federal contract award to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract, valued at $222,288.37, is a delivery order under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration (GSA) Schedule contract. The contract is for the provision of molecular infectious disease reagents to the Department of Veterans Affairs' (VA)...
- This federal contract award was made to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, which does not have a set-aside designation, was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 and has a potential value of $190,585.92. Roche Diagnostics has provided critical care analyzers, reagents, test kits,...
- This federal contract award, valued at $678,412.06, was issued by the Veterans Integrated Service Network 1 (VISN 1) of the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the procurement of cost-per-test reagents and supplies, and was not set aside for any specific business type. Roche Diagnostics has previously received...
- This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $283,976.40 firm-fixed-price purchase order is for cost per test reagents, with a completion date of January 31, 2019. This award is not designated as a set-aside contract. Roche Diagnostics has held multiple General Services Administration...
- This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $505,960.52, is a Delivery Order awarded by the U.S. Department of Veterans Affairs (VA) under Roche's General Services Administration (GSA) Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits (FSS-65-VII). The contract is for the provision of reagents, with a...
This federal contract award is for the provision of molecular diagnostics reagents and rental services to the Department of Veterans Affairs (VA) Veterans Health Administration. The prime contractor is Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract has a potential value of $212,911.87 and a completion date of September 30, 2022. It is a firm fixed price purchase order contract and does not have a set-aside designation. Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to various federal agencies, including the VA, Department of Defense, Department of Health and Human Services, and others. The award is likely part of Roche's existing General Services Administration (GSA) Schedule contracts for laboratory instruments, equipment, and supplies. Roche has also received subcontract awards to provide medical and surgical equipment or supplies in support of prime contractors. This specific award will enable the VA to acquire the necessary molecular diagnostics reagents and rental services to support its healthcare operations for veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($13k) | 12/2/22 | |
| Not listed | Not listed | $225.5k | 8/1/22 |